Dilip Shanghvi is not one for flamboyant statements or headline-grabbing moves. Yet, over the decades, the soft-spoken Chairman & Managing Director of Sun Pharma has turned the company from a small ...

who is Dilip Shanghvi’s son. Some analysts see Sun Pharma’s growth to be driven by a mix of specialty, ROW and India markets. “We see the company delivering 8-10 per cent revenue growth on a ...

Dilip Shanghvi had said in February that the judgment was crucial for Sun Pharma's future course of action on this drug ...

4.5 lakh crore. She’s also known as the daughter-in-law of Dilip Shanghvi, the founder and managing director of Sun Pharma, who is India’s wealthiest figure in the healthcare industry.

This father-son duo’s pharma company is taking on the likes of Sun Pharma, Abbot Bhavya Kaushal 15 inspiring quotes by Dilip Shanghvi, the man who built India's most valuable pharma company ...

Sun Pharmaceutical Industries stock ended 2.15 per cent higher on Friday after zooming by almost 5 per cent in the morning ...

Sun Pharma’s head of biologics marketing Maureen Shannon said, “We are so honored to partner with Art Garfunkel to share his ...

“Over the years, with Sun Pharma’s strategic interventions, Taro has remained a key player in the generic dermatology market in a challenging environment,” said Dilip Shanghvi, the Indian ...

The acquisition further bolsters our innovative portfolio in onco-derm therapy," said Dilip Shanghvi, Chairman & Managing Director of Sun Pharma.

Founder and MD of Sun Pharma, Dilip Shanghvi as well as Pankaj Patel of Zydus Cadila say that efforts are underway to meet global quality standards in both products and processes. India Post ...